In the present study, the administration of an interferon stimulator, polyinosinic: polycytidylic acid (In:Cn), increased the severity of both experimental Candida albicans and Coccidioides immitis infections in mice, as evidenced by earlier time of death and higher final mortality. In addition, kidney tissue levels of C. albicans at 3 and 5 days after infection were found to be about 40-to 300-fold higher in In:Cn treated mice than in control mice. Experimental Cryptococcus neoformans infection, however, was not significantly affected by In:Cn treatment.
Recently it has been shown that interferon or interferon stimulators may exert a protective effect in a number of experimental infections with nonviral agents. Interferon and four different interferon stimulators, including polyinosinic: polycytidylic acid (In:Cn), have been reported to protect mice against Plasmodium berghei (4) . In addition, In:Cn has been reported to protect mice against infection with a number of different bacteria, although this effect may not always be mediated by interferon (11) . Interferon itself has been reported to inhibit the growth of Toxoplasma gondi in chick and mouse cell monolayers (9) .
The present investigation was designed to study the effect of In:Cn on three experimental fungus infections of mice.
MATERIALS AND METHODS
NIH general-purpose Swiss female mice (18 to 22 g) were used throughout. Double-stranded In:Cn ribonucleic acid duplexes were prepared as described previously (2) ; the final concentration of this material was 0.5 mg/ml. Interferon assays were determined by exposing mouse L cells to the interferon samples overnight. The L cells were then washed and challenged with GD-7 virus at an input multiplicity of 10:1. The hemagglutinin yield of GD-7 virus was determined after another overnight incubation. The interferon titer was taken as the reciprocal of the highest dilution of serum which reduced the hemagglutinin yield of GD-7 virus by 0.5 log10. Titers were adjusted in accordance with a titer obtained with a laboratory reference interferon which was included in each assay. The international reference mouse serum interferon titered 104.1 units/ml. Strain B-311 of Candida albicans was used in the present studies. Inocula were prepared from organisms grown on Sabouraud agar slants for 48 hr at 37 C, and the yeast cell growth was harvested, washed, and suspended in pyrogen-free 0.9% NaCl solution. Organisms were counted directly in a hemocytometer, and the inoculum was adjusted to contain 5 X 10' yeast cells in 0.3 ml. In addition, serial 10-fold dilutions were plated for determination of viable count.
Strain 3769 of Crytococcus neoformans was also used in the present studies. Inocula were prepared in a manner identical to that described for C. albicans. The final inocula also contained 5 X 106 yeast cells in 0.3 ml.
Coccidioides immitis strain 6228 was used and had been cultured at ambient temperature on Sabouraud agar for 15 days before these experiments. Inocula were prepared in the manner already described, except that the final concentration was 100 arthospores per 0.3 ml. In addition to inducing interferon, In:Cn is known to enhance humoral and cellular immune response, to affect the reticuloendothelial system (RES) and, in excessive amounts, to cause drug toxicity (6, 8) . In:Cn also appears to have a direct antitumor effect in some systems (6) VOL. 5, 1972 with recent reports of potentiation of Trypanosoma cruzi infection in mice by In:Cn (5, 7), these results raise the possibility that this drug may have a similar effect in man. Each of the three fungi studied is a human pathogen, and C. albicans infection in particular can be a serious problem in patients with leukemia and other tumors who may also become candidates for In:Cn treatment (1). It should be noted that the degree of potentiation of C. albicans and C. immitis infecti.ons by In:Cn is as great as or greater than we have observed in our laboratory with a variety of immunosuppressive methods, (M. Worthington and H. F. Hasenclever, unpublished observations).
